ATE133681T1 - Mykobakterielle rekombinanten und peptide - Google Patents

Mykobakterielle rekombinanten und peptide

Info

Publication number
ATE133681T1
ATE133681T1 AT88903025T AT88903025T ATE133681T1 AT E133681 T1 ATE133681 T1 AT E133681T1 AT 88903025 T AT88903025 T AT 88903025T AT 88903025 T AT88903025 T AT 88903025T AT E133681 T1 ATE133681 T1 AT E133681T1
Authority
AT
Austria
Prior art keywords
peptides
disclosed
proteins
mycobacterial
recombinants
Prior art date
Application number
AT88903025T
Other languages
English (en)
Inventor
Thomas Shinnick
Richard Houghten
Original Assignee
Scripps Research Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/019,529 external-priority patent/US4952395A/en
Application filed by Scripps Research Inst filed Critical Scripps Research Inst
Application granted granted Critical
Publication of ATE133681T1 publication Critical patent/ATE133681T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/08Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/35Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycobacteriaceae (F)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT88903025T 1987-02-26 1988-02-25 Mykobakterielle rekombinanten und peptide ATE133681T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/019,529 US4952395A (en) 1987-02-26 1987-02-26 Mycobacterial recombinants and peptides
US07/159,667 US4976958A (en) 1987-02-26 1988-02-24 Mycobacterial recombinants and peptides

Publications (1)

Publication Number Publication Date
ATE133681T1 true ATE133681T1 (de) 1996-02-15

Family

ID=26692304

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88903025T ATE133681T1 (de) 1987-02-26 1988-02-25 Mykobakterielle rekombinanten und peptide

Country Status (6)

Country Link
US (3) US4976958A (de)
EP (1) EP0305488B1 (de)
AT (1) ATE133681T1 (de)
AU (1) AU610154B2 (de)
DE (1) DE3854952T2 (de)
NO (1) NO302175B1 (de)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0296158B1 (de) * 1986-03-06 1992-06-17 Commonwealth Scientific And Industrial Research Organisation In-vitro-testverfahren zum nachweis zellulärer immunresponsen
AU2408292A (en) * 1991-07-11 1993-02-11 Regents Of The University Of California, The A method to identify protein sequences that fold into a known three-dimensional structure
WO1994003478A1 (en) * 1992-07-31 1994-02-17 Immulogic Pharmaceutical Corporation Sensitive assay for antigens and antibodies and its use to identify rheumatoid arthritis antigen
US5955077A (en) * 1993-07-02 1999-09-21 Statens Seruminstitut Tuberculosis vaccine
US6991797B2 (en) * 1993-07-02 2006-01-31 Statens Serum Institut M. tuberculosis antigens
US6752993B1 (en) 1993-11-23 2004-06-22 The Regents Of The University Of California Abundant extracellular product vaccines and methods for their production and use
DE69435138D1 (de) 1993-11-23 2008-10-23 Univ California Reichlich vorhandene extrazelluläre produkte und methoden zu ihrer herstellung sowie ihre verwendung
US7300660B2 (en) * 1993-11-23 2007-11-27 The Regents Of The University Of California Abundant extracellular products and methods for their production and use
IL114407A0 (en) 1995-06-30 1995-10-31 Yeda Res & Dev Novel peptides and pharmaceutical compositions comprising them
US6110746A (en) * 1995-06-30 2000-08-29 Yeda Research And Development Co. Ltd. Peptides derived from human heat shock protein 60 for treatment of diabetes, compositions, methods and kits
US6338852B1 (en) 1995-09-01 2002-01-15 Corixa Corporation Compounds and methods for diagnosis of tuberculosis
US6290969B1 (en) 1995-09-01 2001-09-18 Corixa Corporation Compounds and methods for immunotherapy and diagnosis of tuberculosis
US6458366B1 (en) * 1995-09-01 2002-10-01 Corixa Corporation Compounds and methods for diagnosis of tuberculosis
US6592877B1 (en) * 1995-09-01 2003-07-15 Corixa Corporation Compounds and methods for immunotherapy and diagnosis of tuberculosis
CA2193870C (en) * 1995-12-25 2000-07-18 Nobuyuki Ise Treponema pallidum fused antigen and assay for anti-treponema pallidum antibodies using the same fused antigen
US6013660A (en) * 1996-10-02 2000-01-11 The Regents Of The University Of California Externally targeted prophylactic and chemotherapeutic method and agents
US6072048A (en) 1997-03-10 2000-06-06 Cornell Research Foundation, Inc. DNA molecule encoding for cellular uptake of Mycobacterium tuberculosis and uses thereof
US7037510B2 (en) 1997-04-18 2006-05-02 Statens Serum Institut Hybrids of M. tuberculosis antigens
US6555653B2 (en) 1997-05-20 2003-04-29 Corixa Corporation Compounds for diagnosis of tuberculosis and methods for their use
US6613881B1 (en) * 1997-05-20 2003-09-02 Corixa Corporation Compounds for immunotherapy and diagnosis of tuberculosis and methods of their use
US20040013685A1 (en) * 1997-11-10 2004-01-22 Peter Andersen Nucleic acid fragments and polypeptide fragments derived from M. tuberculosis
US6465633B1 (en) 1998-12-24 2002-10-15 Corixa Corporation Compositions and methods of their use in the treatment, prevention and diagnosis of tuberculosis
US8143386B2 (en) * 1999-04-07 2012-03-27 Corixa Corporation Fusion proteins of mycobacterium tuberculosis antigens and their uses
EP1229931A4 (de) * 1999-10-07 2003-05-28 Corixa Corp Fusionsproteine aus mycobacterium tuberculosis
AU2001241738A1 (en) * 2000-02-25 2001-09-03 Corixa Corporation Compounds and methods for diagnosis and immunotherapy of tuberculosis
AU2001249214A1 (en) 2000-03-15 2001-09-24 The Brigham And Women's Hospital, Inc. Suppression of vascular disorders by mucosal administration of heat shock protein peptides
DE60139963D1 (de) * 2000-06-20 2009-10-29 Corixa Corp Fusionsproteine aus mycobakterium tuberculosis
AU2002259316A1 (en) * 2001-05-30 2002-12-09 The United States Of America, As Represented By The Secretary Of The Navy Protein arrays and methods and systems for producing the same
US20030185858A1 (en) * 2001-08-15 2003-10-02 Birkett Ashley J. Immunogenic HBc chimer particles stabilized with an N-terminal cysteine
US7361352B2 (en) * 2001-08-15 2008-04-22 Acambis, Inc. Influenza immunogen and vaccine
US7026465B2 (en) 2002-02-15 2006-04-11 Corixa Corporation Fusion proteins of Mycobacterium tuberculosis
US7351413B2 (en) * 2002-02-21 2008-04-01 Lorantis, Limited Stabilized HBc chimer particles as immunogens for chronic hepatitis
US20060142251A1 (en) * 2002-11-15 2006-06-29 Gunther Harth Anti-microbial agents derived from methionine sulfoximine analogues
US7638271B2 (en) * 2003-07-31 2009-12-29 ICDDR, B: The Center for Health and Population Research Use of antibody from lymphocyte secretions to diagnose active infection
US8163880B2 (en) 2006-02-23 2012-04-24 Era Biotech S.A. Production of biologically active proteins
EP2356133B1 (de) 2008-10-10 2019-07-31 Zera Intein Protein Solutions, S.L. Rekombinante proteinkörper als immunogenspezifische adjuvansien
EP2418284A1 (de) 2010-08-13 2012-02-15 ERA Biotech, S.A. Polypeptidsequenzen zur Induzierung von Proteinkörpern
CN114965631B (zh) * 2022-07-07 2023-05-16 重庆科技学院 一种用于检测铅离子的光电化学传感器的构建方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4575484A (en) * 1980-05-05 1986-03-11 Montefiore Medical Center, Inc. Binding assay for the detection of mycobacteria
US4489158A (en) * 1980-05-05 1984-12-18 Montefiore Hospital And Medical Center, Inc. Binding assay for the detection of mycobacteria
US4769237A (en) * 1983-03-25 1988-09-06 Bittle James L Synthetic picornavirus antigen
GB8404280D0 (en) * 1984-02-17 1984-03-21 Stanford J L Biological preparations
US4689397A (en) * 1985-08-12 1987-08-25 Scripps Clinic And Research Foundation Synthetic polypeptides for detecting mycobacterial infections
US4906742A (en) * 1986-07-31 1990-03-06 Whitehead Institute For Biomedical Research Encoding antigens of M. Leprae
NL8701163A (nl) * 1986-09-09 1988-04-05 Nederlanden Staat Gebruik van een peptide voor de bereiding van preparaten voor het verlichten, het behandelen en de diagnose van autoimmuunziekten, in het bijzonder arthritische toestanden, verbindingen die met dit peptide verwant zijn, alsmede farmaceutische en diagnostische preparaten en testkits.
EP0345299A1 (de) * 1987-02-02 1989-12-13 Whitehead Institute For Biomedical Research Mycobacterium tuberculosis-gene, kodierend für proteinantigene
GB8709803D0 (en) * 1987-04-24 1987-05-28 Mcfadden J J Treatment of crohn's disease &c
NL8703107A (nl) * 1987-12-22 1989-07-17 Nederlanden Staat Polypeptiden en derivaten daarvan, alsmede de toepassing daarvan in farmaceutische en diagnostische preparaten.

Also Published As

Publication number Publication date
US4976958A (en) 1990-12-11
NO885659L (no) 1988-12-20
DE3854952T2 (de) 1996-11-07
US5840855A (en) 1998-11-24
EP0305488B1 (de) 1996-01-31
EP0305488A4 (en) 1991-06-05
AU610154B2 (en) 1991-05-16
NO885659D0 (no) 1988-12-20
DE3854952D1 (de) 1996-03-14
EP0305488A1 (de) 1989-03-08
AU1495688A (en) 1988-09-26
US5478726A (en) 1995-12-26
NO302175B1 (no) 1998-02-02

Similar Documents

Publication Publication Date Title
ATE133681T1 (de) Mykobakterielle rekombinanten und peptide
ES2009238A6 (es) Metodo para producir proteinas de mycobacterium tuberculosis y peptidos antigenicos de las mismas.
NZ502391A (en) Mammalian cytokine: interleukin-B30 and related reagents
DE68929043D1 (de) Für androgen-rezeptor-protein kodierende dna
DE3688920D1 (de) Hybride Polypeptide und Verfahren zu deren Herstellung.
HU9601448D0 (en) Novel apoptosis-modulating proteins, dna encoding the proteins and methods of use thereof
DE69034100D1 (de) Verktorvermittelte genominsertion und expression von dna in bcg
HUT46061A (en) Dna sequences encoding hirudin-like protein and process for producing such proteins
ATE338113T1 (de) Transferrin-rezeptor gene von haemophilus
ATE380867T1 (de) Lactoferrinrezeptorgen von moraxella
DK0479948T3 (da) Sammensætninger og fremgangsmåder til syntese af natriuretisk protein-receptor B og anvendelsesfremgangsmåder
DE69117123D1 (de) Menschliches MK Gen und Protein-Sequenz
DE3583634D1 (de) Gentechnologisches verfahren zur herstellung von human-interleukin-2 und mittel zur durchfuehrung dieses verfahrens.
DE69132889D1 (de) Überlegende thrombomodulinanaloga zur pharmazeutischen verwendung
EP0546087A4 (de)
DE69233245D1 (de) Verfahren zur Herstellung von Peptiden
ATE288488T1 (de) Zusammensetzungen und verfahren zur eliminierung unerwünschter zellen
DE69837265D1 (de) Polypeptide zur regenerierung des nervensystems
DK0667781T3 (da) Peptidbaserede diagnostiske og terapeutiske midler til spondylarthropatier
DK595187A (da) Minactivin og fremgangsmaade til fremstilling deraf
DE3380495D1 (en) Molecular cloning and characterization of the gene sequence coding for porcine relaxin
DK56995A (da) Rekombinante lymphotoxin-varianter
HUP9903075A2 (hu) Sejtciklus ellenőrzőpont gének

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time